Non-alcohol fatty liver disease in Asia: Prevention and planning

World Journal of Hepatology

Volumn 7, Issue 13, 2015, Pages 1788-1796

  Ashtari, Sara ^a   Pourhoseingholi, Mohamad Amin ^a   Zali, Mohamad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asian countries; Metabolic risk factors; Non alcoholic fatty liver disease; Prevention

Indexed keywords

EID: 84936856983     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i13.1788     Document Type: Review

References (108)

1. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161 [PMID: 20460905 DOI: 10.1159/000282080]
2. Conlon BA, Beasley JM, Aebersold K, Jhangiani SS, Wylie-Rosett J. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients 2013; 5: 4093-4114 [PMID: 24152749 DOI: 10.3390/nu5104093]
3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112 [PMID: 16447287 DOI: 10.1002/hep.20973]
4. Fruci B, Giuliano S, Mazza A, Malaguarnera R, Belfiore A. Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. Int J Mol Sci 2013; 14: 22933-22966 [PMID: 24264040 DOI: 10.3390/ijms141122933]
5. Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, Lindor K. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 2005; 41: 64-71 [PMID: 15690483 DOI: 10.1002/hep.20543]
6. Hassan K, Bhalla V, El Regal ME, A-Kader HH. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol 2014; 20: 12082-12101 [PMID: 25232245 DOI: 10.3748/wjg.v20.i34.12082]
7. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023 [PMID: 22488764 DOI: 10.1002/hep.25762]
8. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244 [PMID: 17400323 DOI: 10.1016/j.jhep.2007.02.007]
9. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131 [PMID: 20858492 DOI: 10.1053/j.gastro.2010.09.038]
10. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x]
11. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 2007; 22: 794-800 [PMID: 17498218 DOI: 10.1111/j.1440-1746.2007.04952.x]
12. Kneeman JM, Misdraji J, Corey KE. Secondary causes of nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2012; 5: 199-207 [PMID: 22570680 DOI: 10.1177/1756283x11430859]
13. Wong VW. Nonalcoholic fatty liver disease in Asia: a story of growth. J Gastroenterol Hepatol 2013; 28: 18-23 [PMID: 23094755 DOI: 10.1111/jgh.12011]
14. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-787 [PMID: 17565630 DOI: 10.1111/ j.1440-1746.2007.05001.x]
15. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-143 [PMID: 16706825 DOI: 10.1111/ j.1440-1746.2005.04086.x]
16. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ, Chen SY. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003; 9: 1106-1110 [PMID: 12717867]
17. Chen QK, Chen HY, Huang KH, Zhong YQ, Han JA, Zhu ZH, Zhou XD. Clinical features and risk factors of patients with fatty liver in Guangzhou area. World J Gastroenterol 2004; 10: 899-902 [PMID: 15040041]
18. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006; 40: 745-752 [PMID: 16940890]
19. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL. Disease progression of nonalcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-974 [PMID: 20581244 DOI: 10.1136/gut.2009.205088]
20. Sylvester JE, Greenberg P, Selch MT, Thomas BJ, Amstutz H. The use of postoperative irradiation for the prevention of heterotopic bone formation after total hip replacement. Int J Radiat Oncol Biol Phys 1988; 14: 471-476 [PMID: 3343154 DOI: 10.5009/ gnl.2012.6.2.149]
21. Huang HL, Lin WY, Lee LT, Wang HH, Lee WJ, Huang KC. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg 2007; 17: 1457-1463 [PMID: 18219772]
22. Kang H, Greenson JK, Omo JT, Chao C, Peterman D, Anderson L, Foess-Wood L, Sherbondy MA, Conjeevaram HS. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 2006; 101: 2247-2253 [PMID: 17032189 DOI: 10.1111/j.1572-0241.2006.00719.x]
23. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526 [PMID: 16941687 DOI: 10.1002/hep.21347]
24. Souza MR, Diniz Mde F, Medeiros-Filho JE, Araújo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012; 49: 89-96 [PMID: 22481692]
25. Targher G, Byrne CD. Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98: 483-495 [PMID: 23293330 DOI: 10.1210/jc.2012-3093]
26. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-1218 [PMID: 17277038 DOI: 10.2337/dc06-2247]
27. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009; 29: 113-119 [PMID: 18384521 DOI: 10.1111/j.1478-3231.2008.01718. x]
28. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117 [PMID: 10644271]
29. Luyckx FH, Desaive C, Thiry A, Dewé W, Scheen AJ, Gielen JE, Lefèbvre PJ. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222-226 [PMID: 9539189]
30. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100 [PMID: 11438497]
31. García-Monzón C, Martín-Pérez E, Iacono OL, Fernández-Bermejo M, Majano PL, Apolinario A, Larrañaga E, Moreno-Otero R. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000; 33: 716-724 [PMID: 11097478]
32. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350 [PMID: 20879883 DOI: 10.1056/NEJMra0912063]
33. Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev 2007; 8: 3-10 [PMID: 17212790 DOI: 10.1111/j.1467-789X.2006.00235.x]
34. Haddad J, Juif JG, Speeg-Schatz C, Messer J. [Unilateral cerebellar atrophy in 2 newborn infants. Value of MRI]. Arch Fr Pediatr 1992; 49: 47-49 [PMID: 1550451 DOI: 10.1136/bmj.333.7564.362]
35. Sidik SM, Rampal L. The prevalence and factors associated with obesity among adult women in Selangor, Malaysia. Asia Pac Fam Med 2009; 8: 2 [PMID: 19358728 DOI: 10.1186/1447-056x-8-2]
36. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93-99 [PMID: 16326822 DOI: 10.1093/ije/dyi272]
37. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681-1688 [PMID: 17098087 DOI: 10.1016/ S0140-6736(06)69703-1]
38. Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P. Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 2001; 25: 1554-1562 [PMID: 11673781 DOI: 10.1038/sj.ijo.0801739]
39. Kim DM, Ahn CW, Nam SY. Prevalence of obesity in Korea. Obes Rev 2005; 6: 117-121 [PMID: 15836462 DOI: 10.1111/j.1467-789X.2005.00173.x]
40. Aekplakorn W, Chaiyapong Y, Neal B, Chariyalertsak S, Kunanusont C, Phoolcharoen W, Suriyawongpaisal P. Prevalence and determinants of overweight and obesity in Thai adults: results of the Second National Health Examination Survey. J Med Assoc Thai 2004; 87: 685-693 [PMID: 15279350]
41. World Health Organization. Noncommunicable diseases report, chapter 1: mortality, morbidity and risk factors. 2011. Available from: URL: http://www.who.int/nmh/publications/ ncd_report_full_en.pdf
42. Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6: 263-273 [PMID: 24868320 DOI: 10.4254/wjh.v6.i5.263]
43. Sohrabpour A, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S, Pourshams A. Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. Middle East J Dig Dis 2010; 2: 14-19 [PMID: 25197507]
44. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508-514 [PMID: 16006003 DOI: 10.1016/j.jhep.2005.02.042]
45. Gadsby R. Epidemiology of diabetes. Adv Drug Deliv Rev 2002; 54: 1165-1172 [PMID: 12393299]
46. Bruce DG, Davis WA, Davis TM. Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc 2000; 48: 1449-1453 [PMID: 11083322]
47. International Diabetes Federation. IDF Diabetes Atlas. 4th ed. Brussels Belgium: International Diabetes Federation, 2009
48. Passa P. Diabetes trends in Europe. Diabetes Metab Res Rev 2002;18 Suppl 3: S3-S8 [PMID: 12324978 DOI: 10.1002/dmrr.276]
49. Hussain A, Vaaler S, Sayeed MA, Mahtab H, Ali SM, Khan AK. Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study. Eur J Public Health 2007; 17: 291-296 [PMID: 17008328 DOI: 10.1093/eurpub/ckl235]
50. Lusignan S, Sismanidis C, Carey IM, DeWilde S, Richards N, Cook DG. Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and Wales. BMC Fam Pract 2005; 6: 13 [PMID: 15784133 DOI: 10.1186/1471-2296-6-13]
51. Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 2006; 29: 226-231 [PMID: 16443864 DOI: 10.2337/diacare.29.02.06.dc05-0481]
52. Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013; 1281: 64-91 [PMID: 23551121 DOI: 10.1111/ nyas.12098]
53. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 2007; 86: 353-359 [PMID: 17684205]
54. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/ body fat per cent relationship. Obes Rev 2002; 3: 141-146 [PMID: 12164465]
55. Wong VW. Gestational diabetes mellitus in five ethnic groups: a comparison of their clinical characteristics. Diabet Med 2012; 29: 366-371 [PMID: 21913963 DOI: 10.1111/j.1464-5491.2011.03439. x]
56. Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008; 51: 1781-1789 [PMID: 18726585 DOI: 10.1007/s00125-008-1116-7]
57. Al-Moosa S, Allin S, Jemiai N, Al-Lawati J, Mossialos E. Diabetes and urbanization in the Omani population: an analysis of national survey data. Popul Health Metr 2006; 4: 5 [PMID: 16635266 DOI: 10.1186/1478-7954-4-5]
58. Shetty P, Schmidhuber J. Introductory lecture the epidemiology and determinants of obesity in developed and developing countries. Int J Vitam Nutr Res 2006; 76: 157-162 [PMID: 17243077 DOI: 10.1024/0300-9831.76.4.157]
59. Alhyas L, McKay A, Balasanthiran A, Majeed A. Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review. JRSM Short Rep 2011; 2: 55 [PMID: 21847437 DOI: 10.1258/shorts.2011.011019]
60. Badran M, Laher I. Type II Diabetes Mellitus in Arabic-Speaking Countries. Int J Endocrinol 2012; 2012: 902873 [PMID: 22851968 DOI: 10.1155/2012/902873]
61. Vikram NK, Tandon N, Misra A, Srivastava MC, Pandey RM, Mithal A, Sharma S, Ajmani A, Madhu SV, Batra CM, Gupta N. Correlates of Type 2 diabetes mellitus in children, adolescents and young adults in north India: a multisite collaborative case-control study. Diabet Med 2006; 23: 293-298 [PMID: 16492213 DOI: 10.1111/j.1464-5491.2005.01782.x]
62. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011; 9: 48 [PMID: 21542944 DOI: 10.1186/1741-7015-9-48]
63. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850 [PMID: 11473047 DOI: 10.2337/diabetes.50.8.1844]
64. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16: 421-427 [PMID: 15990591 DOI: 10.1097/01. mol.0000174153.53683.f2]
65. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553 [PMID: 9686693]
66. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 1999; 16: 442-443 [PMID: 10342346]
67. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405 [PMID: 15836888 DOI: 10.1016/s0140-6736(05)66375-1]
68. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497 [PMID: 11368702 DOI: 10.1001/ jama.285.19.2486]
69. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752 [PMID: 16157765 DOI: 10.1161/circulationaha.105.169404]
70. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480 [PMID: 16681555 DOI: 10.1111/j.1464-5491.2006.01858.x]
71. Khunti K, Taub N, Webb D, Srinivasan B, Stockman J, Griffin SJ, Simmons RK, Davies MJ. Validity of self-assessed waist circumference in a multi-ethnic UK population. Diabet Med 2012; 29: 404-409 [PMID: 21988535 DOI: 10.1111/j.1464-5491.2011.03478.x]
72. Hernández Mijares A, Riera Fortuny C, Martínez Triguero ML, Morillas Ariño C, Cubells Cascales P, Morales Suárez-Varela M. [Metabolic syndrome in patients with coronary heart disease. Results of using different diagnostic criteria]. Rev Esp Cardiol 2004; 57: 889-893 [PMID: 15373996 DOI: 10.1016/S1885-5857(06)60655-5]
73. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2: 51S-209S [PMID: 9813653]
74. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645 [PMID: 19805654 DOI: 10.1161/circulationaha.109.192644]
75. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev 2008; 29: 777-822 [PMID: 18971485 DOI: 10.1210/er.2008-0024]
76. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo' A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003; 24: 39-52 [PMID: 12537988 DOI: 10.1016/ S0098-2997(02)00090-0]
77. Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr 2008; 17 Suppl 1: 37-42 [PMID: 18296297]
78. Lameira D, Lejeune S, Mourad JJ. [Metabolic syndrome: epidemiology and its risks]. Ann Dermatol Venereol 2008; 135 Suppl 4: S249-S253 [PMID: 18466792 DOI: 10.1016/s0151-9638(08)70543-x]
79. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60: 199-204 [PMID: 12757982 DOI: 10.1016/ S0168-8227(03)00060-3]
80. Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin 2010; 26: 713-719 [PMID: 20078335 DOI: 10.1185/03007991003590597]
81. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 2006; 23: 441-444 [PMID: 16620275 DOI: 10.1111/j.1464-5491.2006.01866.x]
82. Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res 2009; 2009: 136501 [PMID: 19893638 DOI: 10.1155/2009/136501]
83. Ma WY, Li HY, Hung CS, Lin MS, Chiu FC, Lin CH, Shih SR, Chuang LM, Wei JN. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO. Diabetes Res Clin Pract 2009; 85: 335-341 [PMID: 19608293 DOI: 10.1016/ j.diabres.2009.06.020]
84. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007; 77: 251-257 [PMID: 17234299 DOI: 10.1016/ j.diabres.2006.12.001]
85. Chen HJ, Pan WH. Probable blind spot in the International Diabetes Federation definition of metabolic syndrome. Obesity (Silver Spring) 2007; 15: 1096-1100 [PMID: 17495185 DOI: 10.1038/oby.2007.633]
86. Chuang SY, Chen CH, Chou P. Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Med Assoc 2004; 67: 611-620 [PMID: 15779484]
87. Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY, Chan NN, Chan JC. High prevalence of metabolic syndrome in Hong Kong Chinese--comparison of three diagnostic criteria. Diabetes Res Clin Pract 2005; 69: 160-168 [PMID: 16005365 DOI: 10.1016/j.diabres.2004.11.015]
88. Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens 2006; 19: 339-345 [PMID: 16580566 DOI: 10.1016/j.amjhyper.2005.10.008]
89. Kim HM, Kim DJ, Jung IH, Park C, Park J. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people. Diabetes Res Clin Pract 2007; 77: 99-106 [PMID: 17118477 DOI: 10.1016/j. diabres.2006.10.009]
90. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97: 257-261 [PMID: 15458693 DOI: 10.1016/j.ijcard.2003.11.003]
91. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003; 26: 1781-1785 [PMID: 12766109 DOI: 10.2337/diacare.26.6.1781]
92. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 2001; 24: 275-279 [PMID: 11213878 DOI: 10.2337/diacare.24.2.275]
93. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among arab americans. Diabetes Care 2004; 27: 234-238 [PMID: 14693995 DOI: 10.2337/ diacare.27.1.234]
94. Ghamar Chehreh ME, Vahedi M, Pourhoseingholi MA, Ashtari S, Khedmat H, Amin M, Zali MR, Alavian SM. Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation. Hepat Mon 2013; 13: e7382 [PMID: 23914227 DOI: 10.5812/hepatmon.7382]
95. Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A, Nitzan Kaluski D, Halpern Z, Oren R. Predictors for incidence and remission of NAFLD in the general population during a sevenyear prospective follow-up. J Hepatol 2012; 56: 1145-1151 [PMID: 22245895 DOI: 10.1016/j.jhep.2011.12.011]
96. Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Choudhuri G. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2006; 21: 191-198 [PMID: 16706832 DOI: 10.1111/j.1440-1746.2005.04233. x]
97. Larson-Meyer DE, Heilbronn LK, Redman LM, Newcomer BR, Frisard MI, Anton S, Smith SR, Alfonso A, Ravussin E. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 2006; 29: 1337-1344 [PMID: 16732018 DOI: 10.2337/dc05-2565]
98. Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 2009; 58: 1281-1288 [PMID: 19074179 DOI: 10.1136/gut.2008.151977]
99. Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009; 136: 1552-1560 [PMID: 19208352 DOI: 10.1053/j.gastro.2009.01.048]
100. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54: 603-608 [PMID: 15734833 DOI: 10.2337/diabetes.54.3.603]
101. Clark JM. Weight loss as a treatment for nonalcoholic fatty liver disease. J Clin Gastroenterol 2006; 40 Suppl 1: S39-S43 [PMID: 16540766 DOI: 10.1097/01.mcg.0000168641.31321.fa]
102. Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, Yesilova Z, Gulsen M, Dagalp K. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2004; 19: 537-544 [PMID: 14987322]
103. Nair S, Diehl AM, Wiseman M, Farr GH, Perrillo RP. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 2004; 20: 23-28 [PMID: 15225167 DOI: 10.1111/j.1365-2036.2004.02025.x]
104. Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, Podevin P, Lacorte JM, Bernhardt C, Bruckert E, Grimaldi A, Poynard T. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 2008; 135: 100-110 [PMID: 18503774 DOI: 10.1053/j.gastro.2008.03.078]
105. Omer Z, Cetinkalp S, Akyildiz M, Yilmaz F, Batur Y, Yilmaz C, Akarca U. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2010; 22: 18-23 [PMID: 19667999 DOI: 10.1097/MEG.0b013e32832e2baf]
106. Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, Leshno M, Blendis L, Halpern Z, Oren R. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4: 639-644 [PMID: 16630771 DOI: 10.1016/j.cgh.2006.02.004]
107. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362: 1675-1685 [PMID: 20427778 DOI: 10.1056/NEJMoa0907929]
108. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009; 137: 532-540 [PMID: 19409898 DOI: 10.1053/j.gastro.2009.04.052]